Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.
Desar IM, ter Voert EG, Hambrock T, van Asten JJ, van Spronsen DJ, Mulders PF, Heerschap A, van der Graaf WT, van Laarhoven HW, van Herpen CM. Desar IM, et al. Among authors: van spronsen dj, van laarhoven hw, van der graaf wt, van asten jj, van herpen cm. Cancer Imaging. 2012 Jan 12;11(1):259-65. doi: 10.1102/1470-7330.2011.0032. Cancer Imaging. 2012. PMID: 22245974 Free PMC article.
Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells.
Van Herpen CM, Huijbens R, Looman M, De Vries J, Marres H, Van De Ven J, Hermsen R, Adema GJ, De Mulder PH. Van Herpen CM, et al. Among authors: van de ven j. Clin Cancer Res. 2003 Aug 1;9(8):2950-6. Clin Cancer Res. 2003. PMID: 12912941 Clinical Trial.
Current treatment of renal cell carcinoma.
De Mulder PH, van Herpen CM, Mulders PA. De Mulder PH, et al. Among authors: van herpen cm. Ann Oncol. 2004;15 Suppl 4:iv319-28. doi: 10.1093/annonc/mdh946. Ann Oncol. 2004. PMID: 15477330 Free article. Review. No abstract available.
Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation.
van Herpen CM, van der Voort R, van der Laak JA, Klasen IS, de Graaf AO, van Kempen LC, de Vries IJ, Boer TD, Dolstra H, Torensma R, van Krieken JH, Adema GJ, De Mulder PH. van Herpen CM, et al. Among authors: van kempen lc, van der laak ja, van der voort r, van krieken jh. Int J Cancer. 2008 Nov 15;123(10):2354-61. doi: 10.1002/ijc.23756. Int J Cancer. 2008. PMID: 18729197 Clinical Trial.
Pharmacokinetics of sunitinib in an obese patient with a GIST.
Desar IM, Burger DM, Van Hoesel QG, Beijnen JH, Van Herpen CM, Van der Graaf WT. Desar IM, et al. Among authors: van hoesel qg, van der graaf wt, van herpen cm. Ann Oncol. 2009 Mar;20(3):599-600. doi: 10.1093/annonc/mdn779. Epub 2009 Jan 19. Ann Oncol. 2009. PMID: 19153120 Free article. No abstract available.
The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.
Desar IM, Mulder SF, Stillebroer AB, van Spronsen DJ, van der Graaf WT, Mulders PF, van Herpen CM. Desar IM, et al. Among authors: van spronsen dj, van der graaf wt, van herpen cm. Acta Oncol. 2009;48(6):927-31. doi: 10.1080/02841860902974167. Acta Oncol. 2009. PMID: 19452305 No abstract available.
Time to target evaluation criteria of targeted therapies.
van Herpen CM, van der Graaf WT, Oyen WJ. van Herpen CM, et al. Among authors: van der graaf wt. Nucl Med Commun. 2009 Jul;30(7):487-9. doi: 10.1097/MNM.0b013e3283294d32. Nucl Med Commun. 2009. PMID: 19512845 No abstract available.
257 results